These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13135374)

  • 21. Further observations on the use of triethylene melamine in neoplastic diseases.
    WRIGHT JC; PRIGOT A; WRIGHT LT; ARONS I
    AMA Arch Intern Med; 1952 Mar; 89(3):387-404. PubMed ID: 14902152
    [No Abstract]   [Full Text] [Related]  

  • 22. Triethylene melamine in the treatment of lymphomas and other neoplastic diseases.
    BURTNER OW; JENSEN LC; RUMBALL JM
    Ann Intern Med; 1953 Jun; 38(6):1222-44. PubMed ID: 13065973
    [No Abstract]   [Full Text] [Related]  

  • 23. [Triethylene melamine, a new agent in the treatment of cancer].
    ROCCHIETTA S
    Boll Chim Farm; 1952 Oct; 91(10):407-9. PubMed ID: 13032250
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of malignant diseases with triethylene melamine].
    ROMEO ORBEGOZO JM
    Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
    [No Abstract]   [Full Text] [Related]  

  • 25. [30 Cases of hemoblastosis and 6 cases of neoplasms of various types treated with triethylenemelamine].
    STORTI E; MANZINI E
    G Ital Chemioter; 1954; 1(1):116-9. PubMed ID: 13191601
    [No Abstract]   [Full Text] [Related]  

  • 26. Experience with triethylene melamine (TEM) and triethylene thiophosphoramide (thioTEPA) in recurrent or metastatic solid tumors.
    SCHELL RF; HALL BE
    Surg Gynecol Obstet; 1958 Apr; 106(4):459-65. PubMed ID: 13529522
    [No Abstract]   [Full Text] [Related]  

  • 27. Observations on the use of triethylene melamine in Hodgkin's disease.
    DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R
    Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528
    [No Abstract]   [Full Text] [Related]  

  • 28. [Triethylene melamine: new chemotherapeutic agent for tumors].
    ROETTEGLIA E
    Minerva Farm; 1953 May; 2(5):177. PubMed ID: 13086708
    [No Abstract]   [Full Text] [Related]  

  • 29. Triethylene melamine therapy in Hodgkin's and other malignant diseases.
    HANSEN PB; BICHEL J
    Acta radiol; 1951 Dec; 36(6):469-76. PubMed ID: 14902588
    [No Abstract]   [Full Text] [Related]  

  • 30. [Triethylene melamine in combination with radiotherapy].
    SARASIN R; DUBOIS-FERRIERE H
    J Belge Radiol; 1951; 34(4):489-93. PubMed ID: 14946150
    [No Abstract]   [Full Text] [Related]  

  • 31. [Triethylene melamine in Hodgkin's disease].
    HOST H; QVIGSTAD G
    Nord Med; 1955 Sep; 54(36):1383-5. PubMed ID: 13266133
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of triethylene melamine in treatment of leukemia and leukosarcoma.
    SILVERBERG JH; DAMESHEK W
    J Am Med Assoc; 1952 Mar; 148(12):1015-21. PubMed ID: 14897704
    [No Abstract]   [Full Text] [Related]  

  • 33. Triethylene melamine in clinical cancer chemotherapy.
    GELLHORN A; KLIGERMAN MM; JAFFE I
    Am J Med; 1952 Oct; 13(4):428-31. PubMed ID: 12985600
    [No Abstract]   [Full Text] [Related]  

  • 34. The treatment of retinoblastoma by radiation and triethylene melamine.
    REESE AB; HYMAN GA; MERRIAN CR; FORREST AW
    Trans Am Acad Ophthalmol Otolaryngol; 1957; 61(4):439-46. PubMed ID: 13467961
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of Hodgkin's disease with triethylene melamine; preliminary report].
    BOLIO MONSREAL E
    Bol Liga Contra Cancer Havana; 1953 Jun; 28(3):56-62. PubMed ID: 13115509
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytotoxic drugs and malignant tumors; action of triethylene melamine, of diethylene-dipropryloxy-benzoquinone and of thiophosphoramide].
    RAVINA A; PESTEL M
    Presse Med (1893); 1958 Mar; 66(17):371-4. PubMed ID: 13542572
    [No Abstract]   [Full Text] [Related]  

  • 37. The oral use of triethylene melamine; a compound with nitrogen mustard-like activity.
    KARNOFSKY DA; BURCHENAL JH; BERNSTEIN JL; SOUTHAM CM
    Acta Unio Int Contra Cancrum; 1953; 9(1):97-100. PubMed ID: 13057680
    [No Abstract]   [Full Text] [Related]  

  • 38. Some clinical experience in the use of triethylene melamine (TEM).
    HAMERMAN DJ; MELAMED S
    J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of polycythemia vera with triethylene melamine; summary of thirty cases.
    ROSENTHAL N; ROSENTHAL RL
    AMA Arch Intern Med; 1952 Sep; 90(3):379-88. PubMed ID: 14952061
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical use of triethylene melamine; report of seventy-five cases.
    BOND WH; ROHN RJ; DYKE RW; FOUTS PJ
    AMA Arch Intern Med; 1953 May; 91(5):602-17. PubMed ID: 13039612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.